DOI: https://doi.org/10.14710/jgi.14.1.86-101

Phytoestrogens and women’s health: Implications for fibroids and breast cancer – a scoping review

1Parkinson School of Public Health, Loyola University Chicago, Chicago, United States

2Marcella Niehoff School of Nursing, Loyola University Chicago, Chicago, United States

Received: 21 Oct 2025; Revised: 29 Nov 2025; Accepted: 1 Dec 2025; Available online: 30 Dec 2025; Published: 30 Dec 2025.

Citation Format:
Abstract

ABSTRACT

Background: As both uterine fibroids and breast cancer are estrogen dependent tumors, it is crucial to understand how phytoestrogen intake affects the development and progression of these conditions. Most of the research in this area has focused on soy isoflavones, yet a plethora of other phytoestrogens exist.

Objective: The aim of this scoping review was to examine the current literature to determine the relationship between phytoestrogen intake, and the development and progression of uterine fibroids and breast cancer.

Methods: The Scopus database was searched to identify relevant articles published within the past five years.

Results: A total of 5,590 articles were identified in the original search, and 22 articles were included in the final review, with a total of 218,752 female participants (>18 years) across all studies. The findings of this scoping review suggest that consuming phytoestrogen-rich foods, such as soy or flaxseeds, either has no effect on breast cancer risk, or that it may possibly decrease the risk of breast cancer Additionally, supplementation with 300-900 mg of epigallocatechin gallate (EGCG), a phytoestrogen found in green tea, shows promise as a complementary treatment for fibroids.

Conclusion: Current evidence suggests that dietary phytoestrogen intake does not increase the risk of breast cancer. Additionally, EGCG may be a future complementary treatment for reducing fibroid size, although more research is needed to confirm this finding.  

Keywords: Breast cancer; EGCG; fibroids; phytoestrogens

Note: This article has supplementary file(s).

Fulltext View|Download |  Research Instrument
Statement of Originality
Subject
Type Research Instrument
  Download (219KB)    Indexing metadata
Keywords: Breast cancer; EGCG; fibroids; phytoestrogens

Article Metrics:

Article Info
Section: Articles
Language : EN
Recent articles
Analysis of providing complementary feeding practice to stunted and non-stunted children aged 6-24 months in Natuna Regency, Indonesia: A qualitative study Determinants of muscle mass in hemodialysis patients: the role of BMI, MUAC, and MAMC Successful exclusive breastfeeding through ‘‘Kiper Si Gizi’’ to mothers since pregnancy More recent articles
Most cited articles
Pengaruh pemberian asi eksklusif dan non eksklusif terhadap mental emosional anak usia 3-4 tahun Front Matter Pengaruh pemberian jus mangga terhadap profil lipid dan malondialdehyde pada tikus yang diberi minyak jelantah Pengaruh pendidikan gizi terhadap pengetahuan dan sikap tentang gizi anak Sekolah Dasar Back-Matter More cited articles
  1. Eltoukhi HM, Modi MN, Weston M, Armstrong AY, Stewart EA. The health disparities of uterine fibroid tumors for African American women: a public health issue. Am J Obstet Gynecol. Mar 2014;210(3):194-9. doi: 10.1016/j.ajog.2013.08.008
  2. Hazimeh D, Coco A, Casubhoy I, Segars J, Singh B. The Annual Economic Burden of Uterine Fibroids in the United States (2010 Versus 2022): A Comparative Cost-Analysis. Reprod Sci. Dec 2024;31(12):3743-3756. doi: 10.1007/s43032-024-01727-0
  3. Yang Q, Ciebiera M, Bariani MV, et al. Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment. Endocr Rev. Jul 13 2022;43(4):678-719. doi: 10.1210/endrev/bnab039
  4. Sohn GS, Cho S, Kim YM, Cho CH, Kim MR, Lee SR. Current medical treatment of uterine fibroids. Obstet Gynecol Sci. Mar 2018;61(2):192-201. doi: 10.5468/ogs.2018.61.2.192
  5. Waks AG, Winer EP. Breast Cancer Treatment: A Review. JAMA. 2019;321(3):288-300. doi: 10.1001/jama.2018.19323
  6. Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel). Aug 25 2021;13(17)doi: 10.3390/cancers13174287
  7. Apostolou P, Fostira F. Hereditary breast cancer: the era of new susceptibility genes. Biomed Res Int. 2013;2013:747318. doi: 10.1155/2013/747318
  8. Viggiani MT, Polimeno L, Di Leo A, Barone M. Phytoestrogens: Dietary Intake, Bioavailability, and Protective Mechanisms against Colorectal Neoproliferative Lesions. Nutrients. Jul 24 2019;11(8)doi: 10.3390/nu11081709
  9. Qin H, Lin Z, Vásquez E, Luan X, Guo F, Xu L. High soy isoflavone or soy-based food intake during infancy and in adulthood is associated with an increased risk of uterine fibroids in premenopausal women: a meta-analysis. Nutr Res. Nov 2019;71:30-42. doi: 10.1016/j.nutres.2019.06.002
  10. Boutas I, Kontogeorgi A, Dimitrakakis C, Kalantaridou SN. Soy Isoflavones and Breast Cancer Risk: A Meta-analysis. In Vivo. Mar-Apr 2022;36(2):556-562. doi: 10.21873/invivo.12737
  11. Information NCfB. PubChem Compound Summary for CID 5280961, Genistein. 2005;
  12. Information NCfB. PubChem Compound Summary for CID 5281708, Daidzein
  13. Information NCfB. PubChem Compound Summary for CID 65064, Epigallocatechin Gallate
  14. Information NCfB. PubChem Compound Summary for CID 5281707, Coumestrol
  15. Information NCfB. PubChem Compound Summary for CID 114739, Enterolactone
  16. Information NCfB. PubChem Compound Summary for CID 115089, Enterodiol
  17. Information NCfB. PubChem Compound Summary for CID 445154, Resveratrol
  18. Zhang D, Al-Hendy M, Richard-Davis G, Montgomery-Rice V, Rajaratnam V, Al-Hendy A. Antiproliferative and proapoptotic effects of epigallocatechin gallate on human leiomyoma cells. Fertil Steril. Oct 2010;94(5):1887-93. doi: 10.1016/j.fertnstert.2009.08.065
  19. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71
  20. Liu F, Peng Y, Qiao Y, et al. Association of urinary phytoestrogens with hormone-related cancers and cancer biomarkers: NHANES 1999-2010. Br J Nutr. Sep 14 2023;130(5):750-764. doi: 10.1017/s0007114522003877
  21. Lee AW, Poynor V, McEligot AJ. Urinary Phytoestrogen Levels Are Associated with Female Hormonal Cancers: An Analysis of NHANES Data From 1999 to 2010. Nutr Cancer. 2022;74(8):2748-2756. doi: 10.1080/01635581.2021.2020304
  22. Bahrami A, Makiabadi E, Jalali S, Heidari Z, Assadi M, Rashidkhani B. Dietary Intake of Polyphenols and the Risk of Breast Cancer: a Case-Control Study. Clin Nutr Res. Oct 2021;10(4):330-340. doi: 10.7762/cnr.2021.10.4.330
  23. Feng X-L, Ho SC, Zhan X-X, et al. Serum isoflavones and lignans and odds of breast cancer in pre- and postmenopausal Chinese women. Menopause. 2021;28(4):413-422. doi: 10.1097/gme.0000000000001715
  24. Ho SC, Yeo W, Goggins W, et al. Pre-diagnosis and early post-diagnosis dietary soy isoflavone intake and survival outcomes: A prospective cohort study of early stage breast cancer survivors. Cancer Treat Res Commun. 2021;27:100350. doi: 10.1016/j.ctarc.2021.100350
  25. Shirabe R, Saito E, Sawada N, et al. Fermented and nonfermented soy foods and the risk of breast cancer in a Japanese population-based cohort study. Cancer Med. Jan 2021;10(2):757-771. doi: 10.1002/cam4.3677
  26. Sim EJ, Ko KP, Ahn C, et al. Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer. Breast Cancer Res Treat. Nov 2020;184(2):615-626. doi: 10.1007/s10549-020-05875-0
  27. Touillaud M, Gelot A, Mesrine S, et al. Use of dietary supplements containing soy isoflavones and breast cancer risk among women aged >50 y: a prospective study. Am J Clin Nutr. Mar 1 2019;109(3):597-605. doi: 10.1093/ajcn/nqy313
  28. Zhang D, Nichols HB, Troester M, Cai J, Bensen JT, Sandler DP. Tea consumption and breast cancer risk in a cohort of women with family history of breast cancer. Int J Cancer. Aug 1 2020;147(3):876-886. doi: 10.1002/ijc.32824
  29. Berrino F, Villarini A, Gargano G, et al. The Effect of Diet on Breast Cancer Recurrence: The DIANA-5 Randomized Trial. Clin Cancer Res. Mar 1 2024;30(5):965-974. doi: 10.1158/1078-0432.Ccr-23-1615
  30. Chang VC, Cotterchio M, Boucher BA, et al. Effect of Dietary Flaxseed Intake on Circulating Sex Hormone Levels among Postmenopausal Women: A Randomized Controlled Intervention Trial. Nutr Cancer. 2019;71(3):385-398. doi: 10.1080/01635581.2018.1516789
  31. Green T, See J, Schauch M, et al. A randomized, double-blind, placebo-controlled, cross-over trial to evaluate the effect of EstroSense® on 2-hydroxyestrone:16α-hydroxyestrone ratio in premenopausal women. Journal of Complementary and Integrative Medicine. 2023;20(1):199-206. doi:doi:10.1515/jcim-2022-0301
  32. Lu LW, Chen NW, Brunder DG, et al. Soy isoflavones decrease fibroglandular breast tissue measured by magnetic resonance imaging in premenopausal women: A 2-year randomized double-blind placebo controlled clinical trial. Clin Nutr ESPEN. Dec 2022;52:158-168. doi: 10.1016/j.clnesp.2022.10.007
  33. Samavat H, Wu AH, Ursin G, et al. Green Tea Catechin Extract Supplementation Does Not Influence Circulating Sex Hormones and Insulin-Like Growth Factor Axis Proteins in a Randomized Controlled Trial of Postmenopausal Women at High Risk of Breast Cancer. J Nutr. Apr 1 2019;149(4):619-627. doi: 10.1093/jn/nxy316
  34. Rajaram N, Yap B, Eriksson M, et al. A Randomized Controlled Trial of Soy Isoflavone Intake on Mammographic Density among Malaysian Women. Nutrients. Jan 6 2023;15(2)doi: 10.3390/nu15020299
  35. Fabian CJ, Khan SA, Garber JE, et al. Randomized Phase IIB Trial of the Lignan Secoisolariciresinol Diglucoside in Premenopausal Women at Increased Risk for Development of Breast Cancer. Cancer Prev Res (Phila). Jul 2020;13(7):623-634. doi: 10.1158/1940-6207.Capr-20-0050
  36. Yang F, Chen Y. Urinary phytoestrogens and the risk of uterine leiomyomata in US women. BMC Womens Health. May 13 2023;23(1):261. doi: 10.1186/s12905-023-02381-5
  37. Langton CR, Harmon QE, Upson K, Baird DD. Soy-Based Infant Formula Feeding and Uterine Fibroid Development in a Prospective Ultrasound Study of Black/African-American Women. Environ Health Perspect. Jan 2023;131(1):17006. doi: 10.1289/ehp11089
  38. Biro R, Richter R, Ortiz M, Sehouli J, David M. Effects of epigallocatechin gallate-enriched green tea extract capsules in uterine myomas: results of an observational study. Arch Gynecol Obstet. May 2021;303(5):1235-1243. doi: 10.1007/s00404-020-05907-6
  39. Adham B, Nahla Wa'er S, Salah Mohamed Ali M, Abdou Saeed A-A. The Use of Green Tea in the Treatment of Symptomatic Uterine Fibroids. International Journal of Health Sciences. 2022/4/2/ 2022;(I):3116-3135. doi: 10.53730/ijhs.v6nS1.5353
  40. Miriello D, Galanti F, Cignini P, Antonaci D, Schiavi MC, Rago R. Uterine fibroids treatment: do we have new valid alternative? Experiencing the combination of vitamin D plus epigallocatechin gallate in childbearing age affected women. Eur Rev Med Pharmacol Sci. Apr 2021;25(7):2843-2851. doi: 10.26355/eurrev_202104_25537
  41. Grandi G, Del Savio MC, Melotti C, Feliciello L, Facchinetti F. Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study. Gynecol Endocrinol. Jan 2022;38(1):63-67. doi: 10.1080/09513590.2021.1991909
  42. Buck K, Zaineddin AK, Vrieling A, Linseisen J, Chang-Claude J. Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr. Jul 2010;92(1):141-53. doi: 10.3945/ajcn.2009.28573
  43. van Die MD, Bone KM, Visvanathan K, et al. Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies. JNCI Cancer Spectrum. 2023;8(1)doi: 10.1093/jncics/pkad104
  44. Uifălean A, Schneider S, Ionescu C, Lalk M, Iuga CA. Soy Isoflavones and Breast Cancer Cell Lines: Molecular Mechanisms and Future Perspectives. Molecules. 2016;21(1):13
  45. Brooks JD, Thompson LU. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol. Apr 2005;94(5):461-7. doi: 10.1016/j.jsbmb.2005.02.002
  46. Sarkar FH, Li Y. Soy isoflavones and cancer prevention. Cancer Invest. 2003;21(5):744-57. doi: 10.1081/cnv-120023773
  47. Dikshit A, Gomes Filho MA, Eilati E, et al. Flaxseed reduces the pro-carcinogenic micro-environment in the ovaries of normal hens by altering the PG and oestrogen pathways in a dose-dependent manner. Br J Nutr. May 14 2015;113(9):1384-95. doi: 10.1017/s000711451500029x
  48. Soleymani S, Habtemariam S, Rahimi R, Nabavi SM. The what and who of dietary lignans in human health: Special focus on prooxidant and antioxidant effects. Trends in Food Science & Technology. 2020/12/01/ 2020;106:382-390. doi: https://doi.org/10.1016/j.tifs.2020.10.015
  49. Meeran SM, Patel SN, Chan TH, Tollefsbol TO. A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells. Cancer Prev Res (Phila). Aug 2011;4(8):1243-54. doi: 10.1158/1940-6207.Capr-11-0009
  50. Islam MS, Parish M, Brennan JT, Winer BL, Segars JH. Targeting fibrotic signaling pathways by EGCG as a therapeutic strategy for uterine fibroids. Sci Rep. May 25 2023;13(1):8492. doi: 10.1038/s41598-023-35212-6

Last update:

No citation recorded.

Last update: 2025-12-30 16:15:11

No citation recorded.